Search
BioLife Solutions Inc
BLFSAdd to Watchlist
36.690USD
-0.160-0.43%
Close 09-18 16:00（ET）
1.79BMarket Cap
LossP/E TTM
BioLife Solutions Inc (BLFS) Stock Price Target & Forecast
Analyst Rating
Based on 9 analysts giving stock ratings to BioLife Solutions Inc in the past month.
Hold
0 Strong Buy
2 Buy
7 Hold
0 Sell
0 Strong Sell
Target Price
31.286USD-14.03%
BLFS Analyst Recommendation Trends
In the current month, BLFS has received 2 Buy Ratings, 7 Hold Ratings, and 0 Sell Ratings. BLFS average Analyst price target in the last month is 31.286.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
0
2
2
2
2
2
2
2
2
7
8
8
8
8
8
8
7
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9
9
10
10
10
10
10
10
BLFS Analyst Rating for Peer Comparison
Updated: Sep 18, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Medtronic PLC
MDT
9
10
11
0
0
30
Dexcom Inc
DXCM
13
13
4
0
0
30
Stryker Corp
SYK
11
13
6
0
0
30
Abbott Laboratories
ABT
11
12
6
0
0
29
Zimmer Biomet Holdings Inc
ZBH
2
6
21
0
0
29
Medline Ord Shs Class A
MDLN
10
12
6
0
0
28
Insulet Corp
PODD
7
8
12
0
0
27
Guardant Health Inc
GH
12
13
2
0
0
27
Tandem Diabetes Care Inc
TNDM
5
8
10
0
0
23
Repligen Corp
RGEN
5
14
3
0
0
22
Financial Forecasting
Based on analysts' estimates, BLFS EPS is projected to reach 0.057 in FY2026Q3, following reported EPS of 0.923 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.02
0.02
0.03
0.06
0.07
Actual
0.23
0.02
0.92
--
--
Surprise
+1160.96%
+22.35%
+2669.28%
--
--
FAQs
What is BioLife Solutions Inc's expected revenue for the next quarter?
BioLife Solutions Inc's expected revenue is 29.17M.
What is BioLife Solutions Inc's price target?
Analysts forecast that BioLife Solutions Inc's price target is USD 31.29, with the highest forecast at USD 33.00 and the lowest forecast at USD 31.00.
How have BioLife Solutions IncBLFS's recent earnings per share performed?
The market expectation was USD 0.92, while BioLife Solutions IncBLFS's earnings per share (EPS) for the previous quarter was USD 0.02. EPS for the next quarter is expected at USD 0.06.
What is the analyst rating for BioLife Solutions Inc?
Based on the ratings of BioLife Solutions Inc's stock from 9 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.